Ro-106-9920

SynDRA canonical compound SYN0079349 — structure-anchored drug synonym record

Clinical phase	Preclinical
Mechanism of action	NFkB pathway inhibitor

Mechanisms of action (all sources)

NFkB pathway inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

MAOB
APEX1
BLM
CYP1A2
CYP2C19
CYP2C9
CYP2D6
CYP3A4
EHMT2
NFKB1
PMP22
TSHR

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CP1A2

Cross-references

PubChem CID: 3906779
ChEMBL: CHEMBL271023
ChEBI: 110186
LINCS BRD: BRD-A53134341

Synonyms

Ro106-9920
RefChem:379331
DTXCID10348743
6-(benzenesulfinyl)tetrazolo[1,5-b]pyridazine
6-(phenylsulfinyl)tetrazolo[1,5-b]pyridazine
Tetrazolo[1,5-b]pyridazine, 6-(phenylsulfinyl)-
NCGC00025292-01
Tocris-1778
orb1704155
SCHEMBL2493539
CHEBI:110186
HMS3268E20
HMS3412H06
HMS3676H06
6-(BENZENESULFINYL)-[1,2,3,4]TETRAZOLO[1,5-B]PYRIDAZINE
MFCD06660085
NSC793725
AKOS024456773
NSC-793725
NCGC00025292-02
MS-32702
DB-383046
HY-107665
CS-0029139
T23242
SR-01000597505
SR-01000597505-1
BRD-A53134341-001-01-6
BRD-A53134341-001-03-2

Look up Ro-106-9920 in the interactive SynDRA portal →